- Home
- AUNA vs CDXC Comparison
AUNA vs CDXC Comparison
Compare AUNA & CDXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUNA
- CDXC
- Stock Information
- Founded
- AUNA 1989
- CDXC 1999
- Country
- AUNA Luxembourg
- CDXC United States
- Employees
- AUNA N/A
- CDXC N/A
- Industry
- AUNA
- CDXC Medicinal Chemicals and Botanical Products
- Sector
- AUNA
- CDXC Health Care
- Exchange
- AUNA NYSE
- CDXC Nasdaq
- Market Cap
- AUNA 521.9M
- CDXC 572.6M
- IPO Year
- AUNA 2024
- CDXC N/A
- Fundamental
- Price
- AUNA $6.61
- CDXC $6.00
- Analyst Decision
- AUNA Strong Buy
- CDXC Strong Buy
- Analyst Count
- AUNA 4
- CDXC 2
- Target Price
- AUNA $13.40
- CDXC $8.00
- AVG Volume (30 Days)
- AUNA 38.5K
- CDXC 732.2K
- Earning Date
- AUNA 11-19-2024
- CDXC 10-31-2024
- Dividend Yield
- AUNA N/A
- CDXC N/A
- EPS Growth
- AUNA N/A
- CDXC N/A
- EPS
- AUNA N/A
- CDXC 0.02
- Revenue
- AUNA $1,168,151,825.00
- CDXC $91,668,000.00
- Revenue This Year
- AUNA $17.06
- CDXC $18.64
- Revenue Next Year
- AUNA $9.63
- CDXC $20.72
- P/E Ratio
- AUNA N/A
- CDXC $301.89
- Revenue Growth
- AUNA 18.72
- CDXC 9.95
- 52 Week Low
- AUNA $6.17
- CDXC $1.36
- 52 Week High
- AUNA $10.85
- CDXC $7.97
- Technical
- Relative Strength Index (RSI)
- AUNA N/A
- CDXC 39.85
- Support Level
- AUNA N/A
- CDXC $6.55
- Resistance Level
- AUNA N/A
- CDXC $7.79
- Average True Range (ATR)
- AUNA 0.00
- CDXC 0.37
- MACD
- AUNA 0.00
- CDXC -0.25
- Stochastic Oscillator
- AUNA 0.00
- CDXC 6.19
About AUNA AUNA S A
Auna SA is a healthcare provider. It operates hospitals and clinics in Mexico, Peru, and Colombia, and provides prepaid healthcare plans in Peru, and dental and vision plans in Mexico. Its network includes several healthcare network facilities, consisting of hospitals, outpatient, prevention, and wellness facilities. The company operates in the following segments; Oncosalud Peru, Healthcare services in Peru, Healthcare services in Colombia, and Healthcare services in Mexico. Key revenue is generated from Peru.
About CDXC ChromaDex Corporation
ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segments namely Consumer Products, Ingredients segment, and Analytical Reference Standards and Services. The majority of the revenue is earned from the Consumer Products segment.